CIM Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,716	Closed	-$287K	–	292
2020 Q3	$287K	Buy	7,716 +112	+1%	+$4.44K	0.11%	174
2020 Q2	$390K	Buy	+7,604	New	+$318K	0.16%	127
2019 Q4	–	Sell	-6,486	Closed	-$238K	–	253
2019 Q3	$238K	Hold	6,486	–	–	0.09%	282
2019 Q2	$302K	Sell	6,486 -658	-9%	-$30.9K	0.11%	233
2019 Q1	$287K	Sell	7,144 -61	-0.8%	-$2.74K	0.11%	247
2018 Q4	$331K	Hold	7,205	–	–	0.14%	187
2018 Q3	$320K	Hold	7,205	–	–	0.11%	257
2018 Q2	$282K	Hold	7,205	–	–	0.1%	288
2018 Q1	$521K	Buy	7,205 +2,911	+68%	+$214K	0.18%	158
2017 Q4	$283K	Sell	4,294 -87	-2%	-$4.68K	0.1%	270
2017 Q3	$220K	Sell	4,381 -4,387	-50%	-$212K	0.08%	300
2017 Q2	$406K	Sell	8,768 -282	-3%	-$10.4K	0.14%	201
2017 Q1	$320K	Sell	9,050 -8,900	-50%	-$204K	0.11%	252
2016 Q4	$225K	Hold	17,950	–	–	0.08%	308
2016 Q3	$249K	Buy	17,950 +680	+4%	+$7.71K	0.1%	293
2016 Q2	$171K	Buy	17,270 +1,720	+11%	+$28.5K	0.07%	282
2016 Q1	$263K	Buy	+15,550	New	+$250K	0.11%	217
2015 Q3	–	Sell	-2,669	Closed	-$218K	–	260
2015 Q2	$218K	Buy	+2,669	New	+$261K	0.1%	227

Other funds holding ESPR